title: 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis.
authors.affiliation: Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
authors.forename: S M
authors.initials: SM
authors.lastname: Lippman
authors.forename: D T
authors.initials: DT
authors.lastname: Donovan
authors.forename: R A
authors.initials: RA
authors.lastname: Frankenthaler
authors.forename: R S
authors.initials: RS
authors.lastname: Weber
authors.forename: C L
authors.initials: CL
authors.lastname: Earley
authors.forename: W K
authors.initials: WK
authors.lastname: Hong
authors.forename: H
authors.initials: H
authors.lastname: Goepfert
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D015474:Isotretinoin / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000473:pathology; D010212:Papilloma / Q000188:drug therapy* / Q000473:pathology; D010865:Pilot Projects; D011446:Prospective Studies; D011994:Recombinant Proteins; D012142:Respiratory Tract Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D015474:Isotretinoin